Revolution Medicines, Inc. (RVMD)
192.17
+11.25
(+6.22%)
USD |
NASDAQ |
Jul 30, 16:00
192.00
-0.17
(-0.09%)
Pre-Market: 08:41
Revolution Medicines EPS Diluted (Quarterly) : -2.291 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.291 |
| December 31, 2025 | -1.855 |
| September 30, 2025 | -1.613 |
| June 30, 2025 | -1.314 |
| March 31, 2025 | -1.134 |
| December 31, 2024 | -1.120 |
| September 30, 2024 | -0.9367 |
| June 30, 2024 | -0.8068 |
| March 31, 2024 | -0.7042 |
| December 31, 2023 | -1.144 |
| September 30, 2023 | -0.9927 |
| June 30, 2023 | -0.9197 |
| March 31, 2023 | -0.7181 |
| December 31, 2022 | -0.6338 |
| September 30, 2022 | -0.8658 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.8242 |
| March 31, 2022 | -0.7773 |
| December 31, 2021 | -0.7135 |
| September 30, 2021 | -0.7199 |
| June 30, 2021 | -0.6035 |
| March 31, 2021 | -0.5279 |
| December 31, 2020 | -0.5136 |
| September 30, 2020 | -0.4195 |
| June 30, 2020 | -0.4632 |
| March 31, 2020 | -0.3684 |
| December 31, 2019 | -0.3194 |
| September 30, 2019 | -0.2999 |
| June 30, 2019 | -0.2317 |
| March 31, 2019 | -0.2251 |
| December 31, 2018 | -0.2349 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Erasca, Inc. | -0.6028 |
| Tango Therapeutics, Inc. | -0.317 |
| Kymera Therapeutics, Inc. | -0.7098 |
| Summit Therapeutics, Inc. | -0.2772 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -453.82M |
| Total Expenses (Quarterly) | 453.82M |
| Enterprise Value | 37.00B |
| Earnings Yield | -3.68% |
| Normalized Earnings Yield | -3.618 |